Putnam Investments’s Assembly Biosciences ASMB Stock Holding History

Putnam Investments’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-30,379	Closed	-$4.43M	–	1244
2016 Q4	$4.43M	Sell	30,379 -454	-1%	-$67.5K	0.01%	618
2016 Q3	$2.67M	Hold	30,833	–	–	0.01%	765
2016 Q2	$2.05M	Hold	30,833	–	–	0.01%	920
2016 Q1	$1.86M	Hold	30,833	–	–	﹤0.01%	967
2015 Q4	$2.78M	Hold	30,833	–	–	0.01%	886
2015 Q3	$3.54M	Hold	30,833	–	–	0.01%	799
2015 Q2	$7.13M	Hold	30,833	–	–	0.01%	586
2015 Q1	$4.9M	Buy	+30,833	New	+$4.17M	0.01%	791

Other funds holding ASMB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Putnam Investments's ASMB Position: Q1 2017 in Review

Putnam Investments sold out of Assembly Biosciences (ASMB) in Q1 2017, closing a stake of 30,379 shares — an estimated $4.43M sold.

Putnam Investments first reported a position in ASMB in Q1 2015 and held it in 8 quarters. The position peaked at $7.13M in Q2 2015. 49 funds tracked by Wall St. Rank hold ASMB as of Q1 2017.

Putnam Investments reported no remaining Assembly Biosciences position as of Q1 2017 after selling out during the quarter.
Putnam Investments sold 30,379 Assembly Biosciences shares in Q1 2017, an estimated $4.43M.
Putnam Investments first reported a position in Assembly Biosciences in Q1 2015 and held it in 8 quarters.
Putnam Investments's Assembly Biosciences position peaked at $7.13M in Q2 2015.
49 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2017.

Based on Putnam Investments's 13F filing for Q1 2017, filed 15 May 2017.